LEIGHA LENTINI: Open Payments
NPI 1740918606 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 47 payments from 18 companies in 2025. Trend: 2023 $503 · 2024 $1,118 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $185 |
| Amgen Inc. | 9 | $161 |
| Lilly USA, LLC | 5 | $100 |
| Exact Sciences Corporation | 3 | $54 |
| Eisai Inc. | 2 | $50 |
| PFIZER INC. | 3 | $49 |
| ABBVIE INC. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: Ozempic, OTEZLA, Leqembi, The Cologuard Plus Collection Kit, BREZTRI, JARDIANCE, Kerendia, KRYSTEXXA.
Industry payments across AL — which companies pay providers there.
